Count on us to flexibly provide a comprehensive range of services and customized
solutions. Clients worldwide have already benefited from our commitment to good
manufacturing practice and total transparency. Our work focuses on recombinant
proteins, plasmid DNA, antibody fragments, and vaccines.
Our seasoned, 160-strong team supports you with process development, supply
of products for clinical trials, commercial production, in-house QC testing, and QP
release. We operate two GMP-compliant production plants with bioreactor capacities
of up to 1500 liters.
Richter-Helm consistently works to the highest standards of pharmaceutical quality.
This has been verified by major regulatory bodies including EMA, FDA, ANVISA,
and MFDS as well as by numerous customer Audits.